60
Views
6
CrossRef citations to date
0
Altmetric
Commentary

Targeting the hypoxia pathway to treat pancreatic cancer

, , &
Pages 2029-2031 | Published online: 08 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Li Duguang, He Jin, Qian Xiaowei, Xu Peng, Wang Xiaodong, Li Zhennan, Qian Jianjun & Yao Jie. (2017) The involvement of lncRNAs in the development and progression of pancreatic cancer. Cancer Biology & Therapy 18:12, pages 927-936.
Read now

Articles from other publishers (5)

Derek P. Logsdon, Fenil Shah, Fabrizio Carta, Claudiu T. Supuran, Malgorzata Kamocka, Max H. Jacobsen, George E. Sandusky, Mark R. Kelley & Melissa L. Fishel. (2018) Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival. Scientific Reports 8:1.
Crossref
Divya Murthy, Enza Vernucci, Gennifer Goode, Jaime Abrego & Pankaj K. Singh. 2018. Hypoxia. Hypoxia 81 93 .
Vito Longo, Oronzo Brunetti, Antonio Gnoni, Stefano Cascinu, Giampietro Gasparini, Vito Lorusso, Domenico Ribatti & Nicola Silvestris. (2016) Angiogenesis in pancreatic ductal adenocarcinoma: A controversial issue. Oncotarget 7:36, pages 58649-58658.
Crossref
Xiaoyi Huang, Xiaosong Zhi, Yisha Gao, Na Ta, Hui Jiang & Jianming Zheng. (2016) LncRNAs in pancreatic cancer. Oncotarget 7:35, pages 57379-57390.
Crossref
Saba Valadkhan & Alberto Valencia-Hipólito. 2016. Long Non-coding RNAs in Human Disease. Long Non-coding RNAs in Human Disease 203 236 .